Investor Update: Faron Pharma Encouraged by Clevegen's Efficiency and Tolerability



[ad_1]

Key news from the Proactive Investors UK press room.

Faron Pharmaceuticals (LON: FARN) has reported increased immune cell activity as part of the ongoing Phase I / II trial of Clevegen solid tumor cancer treatment. The nine treated patients also tolerated high doses.

Pan African Resources' Pan African Resources (LON: PAF) mine, a South African gold mine, has largely beaten its production forecast of 170,000 ounces for the year ending in June. The miner also sold 11% of its output next year at a price of US $ 1,414 per ounce.

Iofina (LON: IOF) has increased its iodine production by almost 10% in the first half of 2019. Spot prices have also increased.

WPP shareholders receive a special dividend of £ 1 billion after selling 60% of the Kantar market research group to the private equity group Bain.

The troubled holiday group, Thomas Cook, talks about a £ 750 million injection of new money by the main shareholder Fosun.

Insurer Hiscox has confirmed that it will strengthen its reserves because of the rapidly escalating costs of Typhoon Jebi in Japan and Hurricane Michael in Florida. A good investment performance has offset some of this additional cost and the intermediate profits will be between US $ 150 and US $ 170 million or will have changed little compared to the last time.

[ad_2]
Source link